Table 1 Results representing the annexin assay after treatment of pancreatic cancer cells with MFX/CFX
MIA Pa Ca-2 | 24Â h | 48Â h | Panc-1 | 24Â h | 48Â h |
|---|---|---|---|---|---|
0 μg/ml | 5 ± 2 % | 1.6 ± 0.5 % | 0 μg/ml | 5.2 ± 0.58 % | 4.2 ± 2.7 % |
MFX 100 μg/ml | 4.3 ± 0.64 % | 4.4 ± 0.85 % | MFX 100 μg/ml | 2.1 ± 2.7 % | 4.6 ± 3.5 % |
MFX 200 μg/ml | 4.9 ± 0.6 % | 5.9 ± 0.4 % | MFX 200 μg/ml | 3.3 ± 1.59 % | 7.9 ± 1.2 % |
MFX 400 μg/ml | 12.8 ± 1.2 % | 23.4 ± 2 % | MFX 400 μg/ml | 13 ± 1.15 % | 16.9 ± 1.99 % |
CFX 100 μg/ml | 7.5 ± 0.3 % | 7.9 ± 2.45 % | CFX 100 μg/ml | 9.2 ± 1.8 % | 9.8 ± 1.5 % |
CFX 200 μg/ml | 13.8 ± 0.6 % | 22.5 ± 2 % | CFX 200 μg/ml | 19 ± 3.4 % | 14.6 ± 0.78 % |
CFX 400 μg/ml | 18.2 ± 0.2 % | 40.6 ± 2.2 % | CFX 400 μg/ml | 20.5 ± 1.8 % | 21.6 ± 1.4 % |